Chemomab Therapeutics Ltd - ADR

NASDAQ:CMMB  
2.94
-0.06 (-2.00%)
Earnings Announcements

Chemomab Therapeutics Announces First Quarter 2022 Financial Results And Provides Corporate Update

Published: 05/12/2022 10:22 GMT
Chemomab Therapeutics Ltd - ADR (CMMB) - Chemomab Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update.
Q1 Loss per Share $0.02.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.